Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.80
Delayed Data
As of May 22
 -0.0269 / -3.25%
Today’s Change
0.30
Today|||52-Week Range
2.10
0.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization678.5K677.3K677.5K679.7K
 
 
 
 
 
 
Operating ExpensesGross Income-678.5K-677.3K-677.5K-679.7K
 
 
 
 
 
General Expenses20.8M13.7M12.4M16.1M
 
 
 
 
 
Research And Development8.8M5.0M3.6M5.1M
 
 
 
 
 
Total Operating Expenses21.4M14.3M13.0M16.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.4M-14.3M-13.0M-16.8M
 
 
 
 
 
Extraordinary Credit2.0M1.8M0.006.6M
 
 
 
 
Extraordinary Charge0.000.00-14.7M0.00
 
 
Other Expenses1.5K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.4M-12.6M-27.7M-10.2M
 
 
 
 
 
Preferred Dividend-247.0K-183.2K-1.2M0.00
 
 
 
 
Net Income-19.4M-12.6M-27.7M-10.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS105.7M113.0M132.0M175.8M
 
 
 
 
 
Shares To Calculate EPS Diluted105.7M113.0M132.0M175.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.11-$0.22-$0.06
 
 
 
 
 
EPS Diluted-$0.19-$0.11-$0.22-$0.06
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account